CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | WILSON KAREN J Director | Purchase | +10,000 | $1.77 | $18K | 10,000 |
| 2026-05-21 | CURHAN GREGORY S Chief Financial Officer | Grant or award · Stock Option (right to buy) | +123,019 | 123,019 | ||
| 2026-05-21 | LEDGER STEVEN A Chief Executive Officer | Grant or award · Stock Option (right to buy) | +380,825 | 380,825 | ||
| 2026-05-19 | Marshall Richard Peter Director | Purchase | +12,183 | $1.65 | $20K | 12,183 |
| 2026-03-31 | Venkatesan Jay Director | Grant or award | +7,553 | $1.94 | $15K | 7,553 |
| 2026-03-31 | Bailey Gregory Director | Grant or award | +59,667 | $1.94 | $116K | 126,910 |
| 2026-03-23 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 |
| 2026-03-23 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −6,500 | $2.86 | $19K | 0 |
| 2026-03-23 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 267,686 | ||
| 2026-03-19 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +39,000 | $0.06 | $2K | 39,000 |
| 2026-03-19 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −39,000 | $2.50 | $98K | 0 |
| 2026-03-19 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −39,000 | 274,186 | ||
| 2026-02-03 | Tenjarla Srini SVP, CMC & Formulation | Grant or award · Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2026-02-03 | Moreadith Randall Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2026-02-03 | GILL SIMBA Director | Grant or award · Stock Option (right to buy) | +92,000 | 92,000 | ||
| 2026-02-03 | LEDGER STEVEN A Chief Executive Officer | Grant or award · Stock Option (right to buy) | +230,100 | 230,100 | ||
| 2026-02-02 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 |
| 2026-02-02 | Moreadith Randall Chief Scientific Officer | Sale 10b5-1 | −6,500 | $3.03 | $20K | 0 |
| 2026-02-02 | Moreadith Randall Chief Scientific Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 313,186 | ||
| 2026-01-28 | Moreadith Randall Chief Scientific Officer | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 |
Page 2 of 12 · 223 trades